S. B. Debast

4.2k total citations · 2 hit papers
24 papers, 2.1k citations indexed

About

S. B. Debast is a scholar working on Infectious Diseases, Epidemiology and Critical Care and Intensive Care Medicine. According to data from OpenAlex, S. B. Debast has authored 24 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 14 papers in Epidemiology and 3 papers in Critical Care and Intensive Care Medicine. Recurrent topics in S. B. Debast's work include Clostridium difficile and Clostridium perfringens research (11 papers), Microscopic Colitis (9 papers) and Viral gastroenteritis research and epidemiology (8 papers). S. B. Debast is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (11 papers), Microscopic Colitis (9 papers) and Viral gastroenteritis research and epidemiology (8 papers). S. B. Debast collaborates with scholars based in Netherlands, United States and Germany. S. B. Debast's co-authors include Ed J. Kuijper, Martijn P. Bauer, Abraham Goorhuis, Aldert A. Bergwerff, Céline Harmanus, Daan W. Notermans, Dennis Bakker, Friedo W. Dekker, Jeroen Corver and L.A.M.G. van Leengoed and has published in prestigious journals such as Clinical Infectious Diseases, Emerging infectious diseases and Environmental Microbiology.

In The Last Decade

S. B. Debast

22 papers receiving 2.1k citations

Hit Papers

European Society of Clinical Microbiology and Infectious ... 2008 2026 2014 2020 2013 2008 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. B. Debast Netherlands 15 1.9k 1.4k 396 323 231 24 2.1k
Dale N. Gerding United States 15 1.4k 0.7× 936 0.7× 303 0.8× 294 0.9× 155 0.7× 17 1.7k
Scott Curry United States 13 2.0k 1.0× 1.4k 1.0× 445 1.1× 362 1.1× 317 1.4× 32 2.1k
Elena Reigadas Spain 19 1.1k 0.6× 771 0.5× 176 0.4× 216 0.7× 224 1.0× 63 1.3k
M.P.M. Hensgens Netherlands 15 1.2k 0.6× 844 0.6× 237 0.6× 265 0.8× 167 0.7× 19 1.3k
Torbjörn Norén Sweden 19 1.2k 0.6× 787 0.6× 245 0.6× 224 0.7× 247 1.1× 39 1.4k
Frédéric Barbut France 14 737 0.4× 555 0.4× 154 0.4× 113 0.3× 113 0.5× 38 950
Fred A. Zar United States 10 966 0.5× 847 0.6× 281 0.7× 159 0.5× 61 0.3× 19 1.2k
G.E. Bignardi United Kingdom 10 606 0.3× 428 0.3× 106 0.3× 146 0.5× 106 0.5× 18 827
Adriana Hristea Romania 13 604 0.3× 367 0.3× 185 0.5× 82 0.3× 113 0.5× 81 849
Brian P. Buggy United States 14 560 0.3× 454 0.3× 122 0.3× 74 0.2× 81 0.4× 27 899

Countries citing papers authored by S. B. Debast

Since Specialization
Citations

This map shows the geographic impact of S. B. Debast's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. B. Debast with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. B. Debast more than expected).

Fields of papers citing papers by S. B. Debast

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. B. Debast. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. B. Debast. The network helps show where S. B. Debast may publish in the future.

Co-authorship network of co-authors of S. B. Debast

This figure shows the co-authorship network connecting the top 25 collaborators of S. B. Debast. A scholar is included among the top collaborators of S. B. Debast based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. B. Debast. S. B. Debast is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Venekamp, Roderick P, Irene Veldhuijzen, Karel G.M. Moons, et al.. (2022). Detection of SARS-CoV-2 infection in the general population by three prevailing rapid antigen tests: cross-sectional diagnostic accuracy study. BMC Medicine. 20(1). 97–97. 9 indexed citations
3.
Winkel, Béatrice M. F., Hendrik Gremmels, S. B. Debast, et al.. (2021). Screening for SARS-CoV-2 infection in asymptomatic individuals using the Panbio COVID-19 antigen rapid test (Abbott) compared with RT-PCR: a prospective cohort study. BMJ Open. 11(10). e048206–e048206. 20 indexed citations
4.
Bruins, Marjan J., et al.. (2020). Outbreak of Arcanobacterium haemolyticum in chronic wounds in The Netherlands. Journal of Hospital Infection. 105(4). 691–697. 1 indexed citations
5.
Bruins, Marjan J., et al.. (2019). VIM-carbapenemase-producing Escherichia coli in a residential care home in The Netherlands. Journal of Hospital Infection. 104(1). 20–26. 7 indexed citations
8.
Goorhuis, Abraham, S. B. Debast, Céline Harmanus, et al.. (2011). Type-Specific Risk Factors and Outcome in an Outbreak With 2 Different Clostridium difficile Types Simultaneously in 1 Hospital. Clinical Infectious Diseases. 53(9). 860–869. 56 indexed citations
9.
Debast, S. B., et al.. (2009). Successful combat of an outbreak due to Clostridium difficile PCR ribotype 027 and recognition of specific risk factors. Clinical Microbiology and Infection. 15(5). 427–434. 60 indexed citations
10.
Goorhuis, Abraham, Dennis Bakker, Jeroen Corver, et al.. (2008). Emergence ofClostridium difficileInfection Due to a New Hypervirulent Strain, Polymerase Chain Reaction Ribotype 078. Clinical Infectious Diseases. 47(9). 1162–1170. 516 indexed citations breakdown →
11.
Debast, S. B., et al.. (2008). Effect on diagnostic yield of repeated stool testing during outbreaks of Clostridium difficile-associated disease. Clinical Microbiology and Infection. 14(6). 622–624. 25 indexed citations
12.
Debast, S. B., L.A.M.G. van Leengoed, Abraham Goorhuis, et al.. (2008). Clostridium difficile PCR ribotype 078 toxinotype V found in diarrhoeal pigs identical to isolates from affected humans. Environmental Microbiology. 11(2). 505–511. 149 indexed citations
13.
Kuijper, Ed J., Renate J. van den Berg, S. B. Debast, et al.. (2006). Clostridium difficileRibotype 027, Toxinotype III, the Netherlands. Emerging infectious diseases. 12(5). 827–830. 114 indexed citations
14.
Steenbergen, Jim van, S. B. Debast, E. van Kregten, et al.. (2005). Isolation of Clostridium difficile ribotype 027, toxinotype III in the Netherlands after increase in C. difficile-associated diarrhoea. Weekly releases (1997–2007). 10(28). E050714.1–E050714.1. 34 indexed citations
15.
Brinkman, Kees, et al.. (1998). Toxoplasma retinitis/encephalitis 9 months after allogeneic bone marrow transplantation. Bone Marrow Transplantation. 21(6). 635–636. 46 indexed citations
16.
Debast, S. B., Arno van Heijst, Klasien A. Bergman, & Joep M.D. Galama. (1996). A case of severe adenovirus pneumonia in a neonate. Clinical Microbiology and Infection. 1(4). 278–279. 5 indexed citations
17.
Debast, S. B., Jacques F. Meis, Willem J. G. Melchers, J. A. A. Hoogkamp‐Korstanje, & Andreas Voß. (1996). Use of Interrepeat PCR Fingerprinting to Investigate an Acinetobacter baumannii Outbreak in an Intensive Care Unit. Scandinavian Journal of Infectious Diseases. 28(6). 577–581. 21 indexed citations
18.
Debast, S. B., et al.. (1995). Epidemiological survey of an outbreak of multiresistantSerratia marcescens by PCR-fingerprinting. Infection. 23(5). 267–271. 19 indexed citations
19.
Helders, Paul J.M., et al.. (1989). Effects of a tactile stimulation/range‐finding programme on the development of VLBW‐neonates during the first year of life. Child Care Health and Development. 15(6). 369–379. 13 indexed citations
20.
Helders, Paul J.M., et al.. (1988). The effects of a tactile stimulation/range‐finding programme on the development of very low birth weight infants during initial hospitalization. Child Care Health and Development. 14(5). 341–354. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026